MedTrace Logo

Melatonin in Patients Under Carotid Endarterectomy

NCT03115034 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2017-11-07

No results posted yet for this study

Summary

The main purpose of this study is to evaluate the effects of melatonin in the regulation of the vascular injury in patients under carotid endarterectomy through population-based, randomized, double-blind, placebo-controlled trial.

Conditions

  • Carotid Stenosis

Interventions

DRUG

Melatonin

Patients under CEA taking 6mg/day melatonin orally from 3 days before operation to 3 days after operation.

DRUG

placebo

Patients under CEA taking placebo orally from 3 days before operation to 3 days after operation.

OTHER

blank

Patients under CEA without taking melatonin or placebo

Sponsors & Collaborators

  • Peking Union Medical College Hospital

    lead OTHER

Principal Investigators

  • Changwei Liu, MD · Peking Union Medical College Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-06-01
Primary Completion
2017-06-01
Completion
2017-11-01

Countries

  • China

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03115034 on ClinicalTrials.gov